A meeting of the Advisory Committee on Medicines Scheduling (ACMS).
Members
The committee members are professionals with specific scientific, medical or clinical expertise, or expertise in consumer health issues relating to medicines.
Pre-meeting notice
For the pre-meeting public consultation notice go to:
Outcomes
-
Scheduling submissionsPublic submissions on matters referred to the March 2020 scheduling meetings, and received during the interim consultation period - melatonin
-
Scheduling decisions (final)Public notice of the Delegates' final decisions to amend (or not amend) the current Poisons Standard in relation to melatonin.
-
Scheduling submissionsPublic submissions on matters referred to the March 2020 scheduling meetings, and received during the interim consultation period